Objectives The treatment of inflammatory bowel disease (IBD) has been revolutionized by the use of immunomodulatory agents. Although these potent drugs are effective in controlling disease activity, they also cause an increased risk of new infections or reactivation of latent infections. On these premises, we aimed to provide guidance on the definitions of immunocompromised patients, opportunistic infections and the risk factors associated with their occurrence in an IBD context, and to suggest the proper screening tests for infectious diseases and the vaccination schedules to perform before and/or during therapy with immunomodulators. Methods All the most recent evidences – filtered by the combined work of gastroenterologists and infectious disease experts – were summarized with the aim to provide a practical standpoint for the physician. Results A systematic screening of all infections which may arise during therapy with immunomodulator drugs is necessary in all patients with IBD. Conclusions The ideal timing to perform screening tests and vaccinations is at the diagnosis of the disease, regardless of its severity at onset, because the course of IBD and its treatment may vary over time, and an immunocompromised status may hamper efficacy and/or possibility to perform all necessary vaccines.

Mazzola, G., Macaluso, F.S., Adamoli, L., Renna, S., Cascio, A., & Orlando, A. (2017). Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease. JOURNAL OF INFECTION, 74(5), 433-441 [10.1016/j.jinf.2017.02.009].

Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease

Macaluso, Fabio Salvatore;Adamoli, Lucia;Renna, Sara;Cascio, Antonio;Orlando, Ambrogio
2017

Abstract

Objectives The treatment of inflammatory bowel disease (IBD) has been revolutionized by the use of immunomodulatory agents. Although these potent drugs are effective in controlling disease activity, they also cause an increased risk of new infections or reactivation of latent infections. On these premises, we aimed to provide guidance on the definitions of immunocompromised patients, opportunistic infections and the risk factors associated with their occurrence in an IBD context, and to suggest the proper screening tests for infectious diseases and the vaccination schedules to perform before and/or during therapy with immunomodulators. Methods All the most recent evidences – filtered by the combined work of gastroenterologists and infectious disease experts – were summarized with the aim to provide a practical standpoint for the physician. Results A systematic screening of all infections which may arise during therapy with immunomodulator drugs is necessary in all patients with IBD. Conclusions The ideal timing to perform screening tests and vaccinations is at the diagnosis of the disease, regardless of its severity at onset, because the course of IBD and its treatment may vary over time, and an immunocompromised status may hamper efficacy and/or possibility to perform all necessary vaccines.
Settore MED/17 - Malattie Infettive
http://www.elsevier.com/inca/publications/store/6/2/3/0/5/4/index.htt
Mazzola, G., Macaluso, F.S., Adamoli, L., Renna, S., Cascio, A., & Orlando, A. (2017). Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease. JOURNAL OF INFECTION, 74(5), 433-441 [10.1016/j.jinf.2017.02.009].
File in questo prodotto:
File Dimensione Formato  
Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease.pdf

non disponibili

Dimensione 387.63 kB
Formato Adobe PDF
387.63 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/290587
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 18
social impact